Increased mortality after successful treatment for Hodgkin's disease

被引:79
作者
Hudson, MM
Poquette, CA
Lee, J
Greenwald, CA
Shah, A
Luo, XL
Thompson, EI
Wilimas, JA
Kun, LE
Crist, WM
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Dept Epidemiol & Biostat, Memphis, TN 38105 USA
[3] St Jude Childrens Res Hosp, Dept Radiat Oncol, Memphis, TN 38105 USA
[4] Univ Tennessee, Coll Med, Dept Pediat, Memphis, TN USA
关键词
D O I
10.1200/JCO.1998.16.11.3592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the impact of treatment toxicity on long-term survival in pediatric Hodgkin's disease. Patients and Methods: We studied late events in 387 patients treated for pediatric Hodgkin's disease on four consecutive clinical trials at St Jude Children's Research Hospital from 1968 to 1990. Relative risks, actuarial risks, and absolute excess risks for cause-specific deaths were calculated. Results: As of April 1997, 316 (82%) of patients were alive, with a median follow vp of 15.1 (range, 2.9 to 28.6) years. In this cohort, which represented 5,623 person-years of follow-up, 71 fatal events resulted from Hodgkin's disease (n = 36), second malignancies (n = 14), infections (n = 7), accidents (n = 7), cardiac disease (n = 6), and asphyxiation (n = 1). The 5-year estimated event-free survival (EFS) for the entire cohort was 79.6% +/- 2.1%, which declined to 63.1% +/- 4.4% by 20 years. Cumulative incidences of cause-specific deaths at 25 years were 9.8% +/- 1.6% for Hodgkin's disease, 8.1% +/- 2.6% for second malignancy, 4.0% +/- 1.8% for cardiac disease, 3.9% +/- 1.5% for infection, and 2.1% +/- 0.8% for accidents. Standardized incidence ratios showed excess risk for all second malignancies (12; 95% confidence interval [CI], 8 to 17), acute myeloid leukemia (81;95% CI, 16 to 237), solid tumors (11;95% CI, 7 to 16), and breast cancer (33; 95% CI, 12 to 72), Standardized mortality ratios also showed excess mortality from cardiac disease (22; 95% CI, 8 to 48) and infection (18; 95% CI, 7 to 38). Conclusion: Compared with age- and sex-matched control populations, survivors of pediatric Hodgkin's disease who were treated before 1990 face an increased risk of early mortality related to second cancers, cardiac disease, and infection. (C) 1998 by American Society of Clinical Oncology.
引用
收藏
页码:3592 / 3600
页数:9
相关论文
共 37 条
[1]   SUBSEQUENT MALIGNANCIES IN CHILDREN AND ADOLESCENTS AFTER TREATMENT FOR HODGKINS-DISEASE [J].
BEATY, O ;
HUDSON, MM ;
GREENWALD, C ;
LUO, XL ;
FANG, L ;
WILIMAS, JA ;
THOMPSON, EI ;
KUN, LE ;
PRATT, CB .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :603-609
[2]   Breast cancer and other second neoplasms after childhood Hodgkin's disease [J].
Bhatia, S ;
Robison, LL ;
Oberlin, O ;
Greenberg, M ;
Bunin, G ;
FossatiBellani, F ;
Meadows, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :745-751
[3]  
Breslow NE, 1987, STAT METHODS CANC RE, VII
[4]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[5]  
*EP SOFTW, 1993, EP PLUS STAT PACK EP
[6]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[7]   EPIDEMIOLOGY OF HODGKINS-DISEASE [J].
GRUFFERMAN, S ;
DELZELL, E .
EPIDEMIOLOGIC REVIEWS, 1984, 6 :76-106
[8]   CARDIAC DISEASE FOLLOWING TREATMENT OF HODGKINS-DISEASE IN CHILDREN AND ADOLESCENTS [J].
HANCOCK, SL ;
DONALDSON, SS ;
HOPPE, RT .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1208-1215
[9]  
HENRYAMAR M, 1990, SEMIN ONCOL, V17, P758
[10]  
HOOPER WC, 1992, CANCER, V70, P1166, DOI 10.1002/1097-0142(19920901)70:5&lt